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ABSTRACT: Research on implant infections requires cooperative efforts and integration between basic
and clinical expertises. An international group of women scientists is acting together in this field. The
main research topics of the participants of this group are described. Formation of bacterial biofilms, an-
tibiotic resistance and production of virulence factors like adhesins and toxins are investigated. New bio-
materials, coatings and drugs designed to inhibit microbial adhesion are evaluated, and infection-resis-
tant biomaterials are under study, such as a novel heparinizable polycarbonate-urethane (Bionate) or in-
corporation of diamino-diamide-diol (PIME) to reduce bacterial attachment. The correlation between
biofilm production and the accessory-gene-regulator (agr) is investigated in Staphylococcus aureus. The
ability to form biofilm has also been shown to be one of the important virulence factors of Enterococcus
faecalis, favouring colonization of inert and biological surfaces. The study of quorum sensing has led to
the discovery of a quorum sensing inhibitor termed RIP that suppresses staphylococcal biofilm and in-
fections. The immune response and the local defence mechanisms of the host against implant-associat-
ed infections, activation and infiltration of immunocompetent cells into the sites of infection have been
studied in patients with implant-associated osteomyelitis. Production of monoclonal antibodies (mAbs)
as possible vaccines against the staphylococcal collagen-binding MSCRAMMs is in progress. (Int J Artif
Organs 2008; 31: 858-64)
KEY WORDS: Molecular epidemiology, Implant infections, Biofilm, Quorum sensing, Host immune 
response, Infection-resistant biomaterials
INTRODUCTION
Research on implant infections requires cooperative ef-
forts and integration between basic and clinical expertis-
es. An international group of women scientists acting 
together in this field and their lines of research are briefly
presented here.
Carla Renata Arciola, MD, PhD, is Professor of Gen-
eral Pathology at the University of Bologna and Head of
the Research Unit on Implant Infections at the Rizzoli
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Orthopedic Institute, Bologna, Italy. 
Her main research topics concern the study of the etio-
pathogenesis of implant-associated infections, the devel-
opment of new methods for the characterization of viru-
lence factors (1), such as slime (2), adhesins (3, 4), antibi-
otic resistance traits (5, 6) and toxins (7) of bacteria re-
sponsible for orthopedic infections, the evaluation of new
biomaterials and of coatings and drugs designed to in-
hibit microbial adhesion, and the assessment of infec-
tion-resistant biomaterials (8-10). In her laboratory, a
strain library has been created where the bacterial clinical
isolates, responsible for periprosthetic and surgical infec-
tions diagnosed and treated at the Rizzoli Orthopedic In-
stitute, are stored (11). The strain collection currently en-
1. Gertrud Maria Hänsch, 2. Joanna Verran, 3. Naomi Balaban, 4. Elisabeth Presterl, 5. Carla Renata
Arciola, 6. Lucilla Baldassarri, 7. Livia Visai, 8. Stefania Stefani, 9. Katharina Fromm, 10. Ursula Obst.
She is working on a boat on Lake Baikal analyzing the microflora.
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lists over 1800 isolates.
Recent research is focused on molecular epidemiology
of implant infections (12).
In the recent Arciola’s researches, new molecular tech-
niques to profile bacterial genomes and to share bacteria
responsible for infections into groups derived from a com-
mon ancestor have beenapplied to the study of microbial
collections of bacteria from implant infections (13). 
Besides a precise knowledge of the pathogenesis and
epidemiology of implant infections, the goal of these
studies is also the design of infection-resistant biomateri-
als or in the introduction of new preventive or therapeutic
measures as virulence gene silencing strategies.
Naomi Balaban, PhD, is a Faculty member at Tufts
University, Massachusetts, USA. 
Dr. Balaban discovered that virulence in Staphylococ-
cus aureus is autoinduced by molecules secreted by the
bacteria (14). Autocrine regulation in bacteria is now a
well-accepted phenomenon termed quorum sensing, and
is a subject of interest throughout the world. Dr. Balaban
also discovered a quorum sensing inhibitor termed RIP
that suppresses staphylococcal biofilms and infections
(15). She has used multiple device-associated infections
models to show that the quorum sensing inhibitor RIP
can prevent or treat any type of staphylococcal infection,
including those involving antibiotic resistant strains like
MRSA (reviewed in this issue of IJAO). Her studies thus
pave the path for clinical development of quorum sensing
inhibitors as therapeutics for biofilm diseases and device
associated infections (16), currently affecting millions
around the world.
Lucilla Baldassarri, PhD, is Research Manager at the
Department of Infectious, Parasitic and Immunomediated
Diseases, National Institute of Health, Rome, Italy. She
has collaborated for a long time with Arciola’s team on
biofilm production by Staphylococcus aureus and S. epi-
dermidis and the role of biofilm and of its genetic control
as virulence markers in implant and catheter infections
(17). Her research interest in the field of implant infections
is specifically focused on the virulence factors of Entero-
coccus faecalis and on the pathogenesis of infections
caused by enterococci.
Enterococcus faecalis is responsible for the majority of
enterococcal infections, and Enterococcus faecium ac-
counts for about 20 per cent of them. The presence of
implants represents the most relevant risk factor for the
development of enterococcal infections. In the pathogen-
esis of enterococcal implant infections, the ability to form
biofilm has recently been shown to be one of the impor-
tant virulence factors of Enterococcus faecalis, encourag-
ing colonization of inert and biological surfaces, while
protecting bacterial colonies against antimicrobial sub-
stances, and mediating adhesion and invasion of host
cells and survival within professional phagocytes (18).
Biofilm formation has been shown to be particularly im-
portant in the development of prosthetic valve enterococ-
cal endocarditis and stent occlusion. Enterococci are also
able to express other surface factors that may support
colonization of both inert and biological surfaces, and
that may be involved in the invasion of, and survival with-
in, the host cell (19, 20).
Katharina Fromm, is Professor at the University of 
Fribourg, Department of Chemistry. 
Her distinctive research interests are on direct chemical
modification of implant surfaces with bactericidal agents
in order to provide a new generation of self-protective im-
plants (21). This may be an efficient solution for defeating
bacterial adhesion and biofilm formation and should be
an important step in the fight against infections. Silver
coordination polymer compounds combined with antibi-
otic derivatives are currently being tested in micro-biolog-
ical studies for their biocompatibility in leading to soft-
and hard-tissue integration and vascularization.
There is an increasing interest in the coordination
chemistry silver(I) ions in the context of coordination
polymer networks and their polymorphs, as well as in
their biological and pharmaceutical activity (22). The main
ligand used is the ethanediyl bis(isonicotinate) ligand (L)
because (i) it has a flexible backbone; (ii) it contains O-
and N-donor atoms to allow coordination to a “soft”
cation via the nitrogen atoms, and a hard cation via the
oxygen atoms, and, most importantly in this context here,
(iii) it is biocompatible (23).
A study of silver(I) coordination polymer compounds
[AgL](NO3) deposited on metal surfaces as nano-struc-
tured coating, characterized by atomic force microscopy
(AFM), X-ray photoelectron spectroscopy (XPS), and
scanning electron microscopy (SEM), showed good 
in vitro performances of antimicrobial activity against 
S. sanguinis and S. aureus.
Gertrud Maria Hänsch and Ursula Obst. Gertrud
Maria Hänsch is Professor at the University of Heidelberg
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Medical School (Germany), Department of Immunology
and Professor Ursula Obst’s research activity is at the
Department of Environmental Microbiology, Institute for
Technical Chemistry Water Technology and Geotechnolo-
gy, Forschungszentrum Karlsruhe, Germany.
They are mainly interested in the immune response and
the local defence mechanisms of the host against im-
plant-associated infections. They make use of two ap-
proaches:
(i) In patients with implant-associated osteomyelitis, ac-
tivation and infiltration of immunocompetent cells into the
sites of infection (in collaboration with the Trauma Center
Ludwigshafen, Germany) are being studied. Massive infil-
tration of leukocytes into the site of infection, particularly
of polymorphonuclear neutrophils (PMN), have been
found. These cells are highly activated – as shown by the
up-regulation of activation-associated receptors. The
cells were also primed for enhanced oxygen syntheses.
Despite the PMN influx, bacterial biofilm persisted, sug-
gesting that bacteria in biofilms escape the PMN. More-
over, by releasing the cytotoxic and proteolytic activities,
the highly activated PMN contribute to local tissue dam-
age as “collateral damage”. Moreover, activation and infil-
tration of T lymphocytes have been found and phenotyp-
ic and functional characterization of these cells is in
progress.
(ii) The interaction of polymorphonuclear neutrophils
(PMN) with bacterial biofilms is studied in vitro. Phagocy-
tosis of S. aureus biofilms by PMN is under investigation
with the aim of identifying  basic mechanisms, means to
enhance the functional activity of the PMN, and the
means used by the biofilm to defend itself against the
PMN attack.
The interaction of PMN with Pseudomonas aeruginosa,
especially effects of quorum-sensing molecules and of
the extracellular polymer substance on PMN, is a further
field of investigation (24-30).
Elisabeth Presterl is Professor at the Medical Universi-
ty of Vienna, Department of Medicine I, Division of Infec-
tious Diseases and Tropical Medicine. In her experience,
during more than 15 years of infectious diseases consul-
tancy service – particularly dealing with nosocomial infec-
tions – infections of implanted devices, fixation material
or prostheses are still the most wearisome to treat. To
find out why these kinds of infections do not respond to
conventional antimicrobial treatment despite obvious
susceptibility to the administered antimicrobial agents,
the concept of microbial biofilms emerged into medical
microbiology. When testing the antimicrobial susceptibili-
ty of viridians streptococci isolated in patients with endo-
carditis on established biofilms, the results showed that a
dose of at least 32- to 64-fold the MIC of the respective
isolate is needed to reduce the biofilm density and eradi-
cate the bacteria within streptococcal biofilms (31).
Staphylococcal biofilms are by far more resistant to an-
tibiotics. However, alcoholic biocides are bactericidal on
biofilms formed by S. epidermidis isolates of patients
with implant infections and catheter-related bacteremia
within very short incubation time (32). The next goal is to
evaluate effects of standard and newer antibiotics on
biofilms of S. epidermidis clinical isolates and to find 
other supplemental measures to enhance the efficacy of
the antibiotic treatment. During the course of her work,
Presterl’s group has become larger because of interdisci-
plinary cooperation with orthopedic and trauma sur-
geons, the otorhinologists (focusing on dynamic Candida
biofilms of laryngeal protheses) and the dental medical
school.
Stefania Stefani is Professor of Microbiology at the
University of Catania, Department of Microbiological and
Gynecological Sciences. Since 2001, she and her re-
search group (Viviana Cafiso and Taschia Bertuccio) have
added the study on biofilm production in Staphylococcus
spp. to their topics of research. At the beginning, they
started studying S .epidermidis by demonstrating that the
icaRADBC was present in only 45% of the strains and
that these showed a significantly higher percentage of re-
sistance to the major antibiotics tested than the corre-
sponding ica-negative strains. They also demonstrated
that a co-transcription of at least icaAD genes was nec-
essary for biofilm production (33). 
Subsequently, the correlation between biofilm produc-
tion and the accessory-gene-regulator (agr) was investi-
gated in Staphylococcus aureus strains isolated from
CVC infections. They demonstrated that inactivation of
the agr system in agr-II and IB-variant is linked to the
production of a large amount of biofilm in all strains,
which was due to the lack of expression of icaR and rsbU
and a consequent early icaA and atl expression, whereas
the peptidoglycan-hydrolase dltA, responsible for the cell
wall turnover was expressed later (34, 35). 
In an attempt to look at possible anti-biofilm therapies,
a study was started of serratio-peptidase (SPEP) as a
biofilm inhibitor. In preliminary results, it was observed
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that the treatment with this enzyme affects biofilm growth
and protein expression in different Gram-positive bacteri-
al species including Staphylococcus spp. (36).
Investigation into this important aspect of the biology
of microorganisms (above all S. aureus, but also P. aerug-
inosa) is continuing in Stefani’s laboratory. The study of
the involvement of different metabolic and regulatory
genes by measuring the level of expression in different
environmental conditions is currently in progress.
Joanna Verran, is Professor at the Manchester Metro-
politan University, School of Biology, Chemistry and
Health Science, UK. Her research group is diverse and
active, currently comprising besides Professor Verran,
two postdoctoral researchers, and six PhD students. 
The research at MMU focuses on the interactions oc-
curring between microorganisms and inert surfaces,
many of which find use in implants. Other applications in-
clude hygienic food contact surfaces, and external sur-
faces in the hospital environment, where potential exists
for cross-infection. Verran’s group is able to fabricate sur-
faces with defined topography and with metal and alloy
coatings, produced via plasma vapor deposition.
A review of surfaces used in the food industry (37) in-
cludes issues of interest in implant infections, by focusing
on the effect of surface topography and chemistry, and
the presence of organic material on the retention and sur-
vival of microorganisms on these surfaces.
Recent work had provided interesting focus on the sur-
vival of microorganisms on stainless steel and copper
surfaces with potential use in the hospital environment,
subjected to repeated soiling and cleaning cycles. While
stainless steel exerted no antimicrobial effect, it remained
relatively easy to clean: copper was antimicrobial, but tar-
nished rapidly, and lost some antimicrobial properties
due to its reactivity with soil and cleaning formulations.
Implications are discussed in the publication (38).
A different, but very relevant aspect focuses on denture
plaque. Microorganisms isolated from this important but
neglected biofilm include those associated with denture
stomatit is, oral malodor, and some opportunist
pathogens more commonly associated with systemic dis-
ease. Thus denture hygiene and plaque control are im-
portant aspects to maintenance of oral and general
health of this increasing elderly population (39), and the
characteristics of the polymers used to fabricate these
prostheses might be modified to improve overall health
status.
Livia Visai, PhD, is Research Manager at the University
of Pavia, Department of Biochemistry, Italy. 
Her research interest has been focused on staphylococci
as important causes of nosocomial and medical-device-
related infections. In order to prevent or treat bacterial in-
fections of implanted devices, three strategies have been
investigated: a) production of monoclonal antibodies
(mAbs) against the staphylococcal collagen-binding
MSCRAMM (CNA) as a possible vaccine; b) development
of the synthesis of a novel heparinizable polycarbonate-ure-
thane (Bionate) incorporating a tailor-made diamino-di-
amide-diol (PIME) to reduce bacterial attachment; c) photo-
dynamic treatment (PDT) for the inactivation of bacteria in
biofilms. In the first case, mAbs raised against the minimal
ligand binding domain, CNA-(151–318), were able to inhibit
collagen binding to intact S. aureus cells and also to inter-
fere with the attachment of bacteria to collagen substrates.
Some of the mAbs were also able to detach bacteria that
had adhered to a collagen substrate in a preincubation,
raising the possibility that these mAbs may be used as ther-
apeutic agents (40). In the second study, a new synthesized
Bionate-PIME was developed to be used for intravascular
catheters. In vitro bacterial interaction tests showed a de-
crease in colonization of staphylococcal strains on the he-
parinized Bionate-PIME surfaces, confirming that pread-
sorbed heparin plays a role in mediating the biomaterial sur-
face/bacterial cells interactions (41). In the last approach,
the effect of PDT of toluidine blue O (TBO) on the viability
and structure of biofilms of staphylococcal strains was in-
vestigated. Significant inactivation of cells was observed
when staphylococcal biofilms were exposed to TBO and
laser simultaneously. The results suggest that PDT may be
a useful approach for the inactivation of staphylococcal
biofilms already adhering to solid surfaces of medical im-
plants (42).
CONCLUSIONS
An international team of women scientists is engaged
in a cooperative task: combating implant infections. The
team gathers numerous, complementary areas of exper-
tise and is animated by a spirit of collaboration among
the research groups. Collections of hospital and environ-
mental bacterial strains coming from different countries,
an exchange of methods and technologies, and the shar-
ing of information on the scientific progress of each
group will be the targets of the cooperative team. 
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